Cite
Risk of a first clinical diagnosis of central nervous system demyelination in relation to human herpesviruses in the context of Epstein–Barr virus.
MLA
Lucas, Robyn M., et al. “Risk of a First Clinical Diagnosis of Central Nervous System Demyelination in Relation to Human Herpesviruses in the Context of Epstein–Barr Virus.” European Journal of Neurology, vol. 30, no. 9, Sept. 2023, pp. 2752–60. EBSCOhost, https://doi.org/10.1111/ene.15919.
APA
Lucas, R. M., Lay, M. J., Grant, J., Cherbuin, N., Toi, C. S., Dear, K., Taylor, B. V., Dwyer, D. E., Chapman, C., Coulthard, A., Dwyer, T., Kilpatrick, T., Lucas, R., McMichael, T., Ponsonby, A., Taylor, B., Valery, P., van der Mei, I., & Williams, D. (2023). Risk of a first clinical diagnosis of central nervous system demyelination in relation to human herpesviruses in the context of Epstein–Barr virus. European Journal of Neurology, 30(9), 2752–2760. https://doi.org/10.1111/ene.15919
Chicago
Lucas, Robyn M., Meav‐Lang J. Lay, James Grant, Nicolas Cherbuin, Cheryl S. Toi, Keith Dear, Bruce V. Taylor, et al. 2023. “Risk of a First Clinical Diagnosis of Central Nervous System Demyelination in Relation to Human Herpesviruses in the Context of Epstein–Barr Virus.” European Journal of Neurology 30 (9): 2752–60. doi:10.1111/ene.15919.